American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Here’s why Teladoc Health stock price could surge 95%

by admin June 24, 2025
June 24, 2025
Here’s why Teladoc Health stock price could surge 95%

Teladoc Health stock price surged by over 14% on Monday, its best single-day gain since April 9. TDOC jumped to a high of $7.90, its highest point since April 9. This article conducts a technical analysis to explain why the TDOC stock may jump by 95% this year.

Teladoc Health stock price analysis

The daily chart shows that the TDOC share price bottomed at $6.7 in 2024 and this year. It has failed to move below that support level at least two times since August 14. 

This means that the stock formed a double-bottom pattern, a popular bullish reversal sign. This pattern comprises two distinct bottoms and a neckline, which in this case, is at $15.20, up by about 95% from the current level. 

Teladoc Health stock price has also gone through a period of consolidation, where it remained inside the channel between $6.77 and $7.66. This consolidation led to a sharp decline of the Average True Range (ATR) and narrowing of the spread between the three lines of Bollinger Bands. 

The consolidation could be part of the accumulation phase of the Wyckoff Method. This phase is characterized by low volume and volatility, and is then followed by the markup phase, which has higher demand than supply. 

Therefore, the stock will likely have a strong bullish breakout in the coming weeks as investors buy the dip. If this happens, it will likely surge to the double-bottom’s neckline at $15.20.

The bullish Teladoc stock forecast will become invalidated if it drops below the double-bottom point at $6.38. Such a move will point to more downside, potentially to the psychological point at $5. 

Teladoc Health stock chart | Source: TradingView

TDOC is facing challenges, but a turnaround could help

It is unclear why the Teladoc Health stock price surged on Monday. However, it is worth noting that this happened on the same day that Hims & Hers stock price plunged by over 34% after losing the valuable Novo Nordisk partnership. 

Teladoc Health has been going through substantial challenges in the past few years as the pandemic boom turned into doom. Its annual revenue moved from $1.09 billion in 2020 to over $2.03 billion in 2021 and $2.4 billion in 2022.

Recently, however, the growth has deteriorated, with its annual revenue in 2024 coming in at $2.56 billion, and analysts anticipate its figure will come in at over $2.52 billion this year. 

All of Telaoc Health’s segments have slowed, with the most pain being in its BetterHelp business. 

The most recent results showed that the company’s first-quarter revenue dropped by 3% to over $629 million and its net loss per share stood at 53 cents. 

Teladoc Health’s Integrated Care Segment, which serves millions of customers, made $389 million, up from $377 million in the same period last year. 

However, its BetterHelp revenue has continued to fall quarter after quarter. Its revenue was $240 million, down from $269 million in the same period last year. It is unclear whether this business will recover as its number of paying users has dropped below 400,000 for the first time in years. 

A potential turnaround strategy would be to divest the BetterHelp segment, potentially to a private equity company. The remaining company would be a specialist in the integrated care business, whose US clients jumped from 91.8 million last year to 102.5 million.

Teladoc Health and analysts believe that the slowdown will continue this year. Management expects the revenue to drop by 4% to $2.46 billion and the loss per share to be between $1.40 and 90 cents.

The post Here’s why Teladoc Health stock price could surge 95% appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
JPMorgan projects another 15-20% surge in Asian tech stocks driven by AI momentum
next post
Starbucks denies plans to fully exit China operations amid rising local competition

Related Posts

Costco stock price chart patterns point to a...

January 9, 2025

Russia’s bad loan crisis: is bailout inevitable by...

July 17, 2025

How will US tariffs affect the TLT and...

February 2, 2025

Inox Green Energy, Premier Energies and six other...

January 21, 2025

Nifty Bank Index best and worst performers in...

December 24, 2024

Bitcoin mutual funds to launch in Israel next...

December 26, 2024

NIO stock: is Onvo L90 launch a big...

July 12, 2025

Long BYRN: Byrna Technologies Surges Past Previous Highs...

February 11, 2025

Apple and Google face UK action over mobile...

July 23, 2025

Symbotic stock sinks 40% after financial errors and...

November 28, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • How Donald Trump’s immigration crackdown may tank the labor market

      August 4, 2025
    • Trump’s tariff threat looms over India’s Russian oil deals

      August 4, 2025
    • Trump moves nuclear submarines near Russia: what triggered the move and what’s ahead

      August 3, 2025
    • BOE rate cuts offer little relief as UK households face mounting financial strain

      August 3, 2025
    • Retail investors shift focus to Europe as US valuations stretch

      August 3, 2025

    Categories

    • Business (3,573)
    • Investing (2,700)
    • Latest News (2,031)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved